Effect of Fluosol-DA on Radioimmunoassay Results
Margareta Hammarstrom, Richard Muiiins, and Demetrios Sgoutas1
Fluosol-DA, an emulsion of pertluorocarbons, isused as a blood substitute. Its presence in samples affects results of certain radioimmunoassays routinely done in our laboratory. In several, added Fluosol-DA caused an upward displacement of the standard curve, the extent of which depended on the structure and quantity of the assayed antigen, the concentration of Fluosol-DA, and the nature of the immunoreagents. Fluosol-DA markedly affected results of assays for triiodothyronine, thyroxiri, and digoxin (by one method), but assays for aminoglycosides and protein hormones were unaffected. We determined that Fluosol-DA interacts with unbound labeled (and, presumably, with unlabeled) antigen to form a complex that coprecipitates with the bound antigen-antibody fraction during the separation step. In comparison with the idealized condition we observed an apparent increase in antibody-bound labeled antigen and consequently an apparent underestimation of the measured antigen. Depending on the nature of the immunoreagents, antibodies can extract more or less of their respective antigens from particles of Fluosol-DA emulsion. 
Materials and Methods
Serum samples. Assuming the average blood volume of 70 mL/kg body weight and average plasma volume of 45 mL/kg (7), the average 70-kg man would have 4900 mL of blood, or 3150 mL of plasma. This "average man" could receive as much as 2100 mL of Fluosol-DA, and a blood sample could contain as much as 400 mL of Fluosol-DA per liter, or 600 mL/L of plasma. Generally, however, the concentration of Fluosol-DA present would be 200-300 mL/L. For the present study we added the final mixture of Fluosol-DA to patients' specimens to give final Fluosol-DA concentrations of 100, 250, and 400 mL/L.
Radioimmunoassays.
We used commercially available kits for all RIA methods. Digoxin, triiodothyronine(T3),and thyroxin (T4) kits were those manufactured by Corning Medical and Scientific, Medfield, MA 02052.2 In these kits, 2 Nonstandard abbreviations: T, triiodothyronine; T4, thyroxin; NML, Nuclear Medical Laboratories. an antibody for digoxin, T3, or T4 is reacted with a trace amount of labeled antigen and a standard or serum sample containing the known or unknown quantity of antigen. The antibody is chemically immobilized on glass particles that have a large surface area and high relative density. The latter allows rapid and quantitative separation of the bound fraction, the radioactivity of which is counted. The counts for standards are used to construct a standard curve, with which the radioactivity of each unknown sample is compared.
Gentamicin were incubated with antibody and radiolabeled antigen, after which an immunoprecipitant was added or a polyethylene glycol-facilitated double-antibody separation agent was used. The reaction mixture was then centrifuged, the antibody-bound antigen precipitating in the pellet. The radioactivity of the pellet was counted. Individual patient's sera and pooled samples with analyte concentrations ranging from high to low were diluted with Fluosol-DA (or with saline, to compensate for dilution effects) and assayed for the respective analyte according to the manufacturer's instructions.
In other experiments we mixed radiolabeled antigens
with various amounts of Fluosol-DA, incubated the mixture for 15 mm at 25 #{176}C, centrifuged the mixture, and counted the radioactivity in the pellets and the supernate separate-
To define the effect of antibody on the Fluosol-DAantigen complex, we suspended the Fluosol-DA pellet containing the radiolabeled antigen in barbital buffer with and without added antibody. We let the mixtures stand for 15 mm, centrifuged them, and counted the radioactivity in both the pellet and the supernate. Radioactivity was measured with a Nal (Ti) scintillation counter. Statistical analyses included the unpaired t-test for comparing means of different determinations in the normal control mean values (in the absence of Fluosol-DA). A pvalue <.05 was considered significant. 2B also shows that there is a significant effect in the digoxin assay with the Corning kit but no effect with either the NML or the Mallinckrodt kit. In an effort to elucidate the mechanism of this effect, we studied the action of Fluosol-DA on several antigens in the absence of antibody. Table 1 shows the results of these Fluosol-DA appears to precipitate with some radiolabeled antigens. This effect was the greatest for T3 and digoxin (Corning kit), and least for tobramycin and the other aminoglycosides tested.
Results
Other experiments (not shown) indicated that radiolabeled proteins such as prolactin, follitropin, lutropin, and somatotropin were not coprecipitated with Fiuosol-DA. Table 1 also shows that under exactly identical conditions the lmIlabeled digoxin component of the Corning kit (a histamine derivative) is more tightly associated with Fluosol-DA particles than is the i251 labeled digoxin derivative of the NML kit (unknown structure). Table 2 shows results from experiments in which the Fluosol-DA pellets containing l125I11 were treated with a buffer solution in the presence or absence of the corresponding antibody. These experiments were designed to determine how tightly the antigen was associated with Fluosol-DA. Wash solutions that contained antibody were effective in removing antigens from the Fluosol-DA pellet, and the effect was a function of the concentration of the antibody. These results strongly suggest a competition between antibody and Fluosol-DA for the association with antigen.
Results from similar experiments conducted with [125lldigoxin from Corning and NML are shown in Table 3 . Washing the pellet in buffer containing antibody removed 
Discussion
Evidently Fluosol-DA can interfere in RIAs and cause errors in data interpretation.
The mechanism of this inter-ference appears to be an association of the antigen with Fluosol-DA. In the separation step, Fluosol-DA coprecipitates with the antigen-antibody complex, which increases the apparent unbound labeled and unlabeled antigen molecules in the pellet. The result is observed as an apparent increase in antibody-bound labeled antigen and, because in our assays the bound fraction is counted and used to construct a standard curve, the measured analyte is also underestimated.
The effect appears to be principallyascribable to a physical interactionbetween Fluosol-DA emulsion particles and antigen molecules, and is highly related to the hydrophobicity of the antigen. The marked effect on the T3 assay, in contrast to the effect on the T4 assay and the lack of interference with protein and aminoglycoside assays, argues in favor of this hypothesis.
The effect of Fluosol-DA differed in each of the systems that we tested. Therefore, the degree of interference produced by Fluosol-DA cannot be predicted and must be separately evaluated for each hormone assay.
Fluosol-DA 20% was suppliedby Alpha Therapeutics Corp., Los Angeles, CA 90032.
